Scinai Immunotherapeutics

SCNINasdaq Israel Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$957.571 K

$1.91 +13.02%

Close of 22 Sept 2026

Revenue

$1.31M

#3460 by revenue

Earnings

-$8.31M

Loss-making

Shares outstanding

13,872,899,584

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#156Calidi BiotherapeuticsCLDI$2.95M
#157Silexion TherapeuticsSLXN$2.26M
#158CurisCRIS$2.09M
#159Tessera Defense & Homeland SecurityHLSQ$1.82M
#160Scinai ImmunotherapeuticsSCNI$957.6K

What if Scinai Immunotherapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$60,305,588

Per share 31,573,606× higher

Bitcoin $1.74T

$3,473,958

Per share 1,818,826× higher

Nvidia $5.52T

$11,001,915

Per share 5,760,165× higher

Or at a round number

$2.00M $5.00M $10.0M $20.0M

Where these numbers come from

Share counts and financials for Scinai Immunotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.